Literature DB >> 24559822

Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.

Dong Il Park1, Jae Myung Cha2, Hyun Soo Kim3, Hong Jun Park3, Jung Eun Shin4, Sung No Hong1, Sung Soo Hong5, Wan Jung Kim6.   

Abstract

OBJECTIVES: The aim of this study was to assess characteristics and predictive factors of complementary and alternative medicine (CAM) use for patients with inflammatory bowel disease (IBD) in Korea.
DESIGN: Prospective, questionnaire based study for patients with IBD in Korea.
SETTING: Six university hospitals and one primary IBD clinic. MAIN OUTCOME MEASURE: Overall characteristics and predictors of CAM use were compared between CAM users and non-users.
RESULTS: During the study period, 366 patients with IBD (ulcerative colitis=228, Crohn's disease=138) completed the full questionnaire; 29.5% (n=108) reported CAM use and 70.5% (n=258) reported no CAM use after diagnosis of IBD. In total, 64.0% were male, the mean patient age was 42.3±15.5 years, and the mean duration of IBD was 5.5±5.8 years. Using logistic regression analysis, university education (p=0.040), higher income levels (p=0.009), and longer duration of IBD (p=0.003) were found to be independent predictors of CAM use. Among CAM users, 65% of CAM was attained within 2 years of IBD diagnosis and only 28.7% discussed CAM use with their physician. Furthermore, 13.9% of CAM users discontinued conventional IBD therapy while using CAM.
CONCLUSIONS: The overall use of CAM in Korea was comparable with those in the West. Physicians should be aware of the high prevalence of CAM use by patients with IBD, especially among those with higher education levels, higher income levels, and longer IBD duration. Furthermore, physicians should ask about CAM use, and help their IBD patients make a more informed choice about CAM use.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complementary and alternative medicine; Crohn's disease; Inflammatory bowel disease; Risk factors; Ulcerative colitis

Mesh:

Year:  2013        PMID: 24559822     DOI: 10.1016/j.ctim.2013.12.001

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  6 in total

1.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Authors:  Steven C Lin; Adam S Cheifetz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

3.  Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?

Authors:  Jae Myung Cha
Journal:  Intest Res       Date:  2020-04-20

4.  The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Authors:  M Ellen Kuenzig; Lawrence Lee; Wael El-Matary; Adam V Weizman; Eric I Benchimol; Gilaad G Kaplan; Geoffrey C Nguyen; Charles N Bernstein; Alain Bitton; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

5.  Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study.

Authors:  Eun Soo Kim; Chung Hyun Tae; Sung-Ae Jung; Dong Il Park; Jong Pil Im; Chang Soo Eun; Hyuk Yoon; Byung Ik Jang; Haruhiko Ogata; Kayoko Fukuhara; Fumihito Hirai; Kazuo Ohtsuka; Jing Liu; Qian Cao
Journal:  Intest Res       Date:  2022-04-29

6.  Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease.

Authors:  Deborah Chew; Wong Zhiqin; Norhayati Ibrahim; Raja Affendi Raja Ali
Journal:  Intest Res       Date:  2018-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.